Dr Jitendra Singh mentioned, almost in passing, that he had performed an ultrasound on a person 10,000 kilometres away in Antarctica.
That single claim contains both the promise of tele-robotics and its limit, and separating the two is the most useful thing a student can take from the day's news.
The Union Minister of State for Science and Technology — himself a physician and diabetologist — was delivering the inaugural address at the International Conference of the Society of Robotic Surgery (SRS India 2026) on 2 October 2026. His argument was that robotics should not be understood as a surgical technology but as a tool that will spread across medicine: "It's a tool. It will happen everywhere," he said, anticipating robotic medicine, robotic endocrinology and robotic cardiology alongside robotic surgery.
How a surgical robot actually works
The first thing to discard is the word "robot" as most people understand it. A surgical robot does not operate autonomously and makes no decisions. It is a master-slave system.
The surgeon sits at a console, usually in the same room, viewing a magnified three-dimensional image from an endoscopic camera and manipulating hand controls. Those movements are transmitted to robotic arms at the patient, each holding an instrument that enters through a small incision. The instrument reproduces what the surgeon's hand did.
What the machine adds is not judgement but mechanical refinement:
- Tremor filtration. Every human hand has a physiological tremor of a few hertz. The system filters it out, so the instrument tip is steadier than any hand can be.
- Motion scaling. A three-centimetre hand movement can be scaled to a three-millimetre instrument movement, giving effective precision beyond unaided human capability.
- Degrees of freedom. Wristed instruments articulate inside the body in ways a rigid laparoscopic tool cannot, allowing the surgeon to work around corners.
- Ergonomics. The surgeon is seated, which matters over an operation lasting hours.
And what it takes away is worth stating, because it is the honest counterweight: most systems provide little or no haptic feedback. The surgeon cannot feel tissue resistance and must infer it visually. Robotic surgery substitutes vision for touch, and that trade is why it suits some procedures far better than others.
Why Antarctica is easier than surgery
Now the limit. The Minister's ultrasound at 10,000 km worked. Surgery at 10,000 km would be a different proposition, and the reason is latency.
Light in optical fibre travels at roughly two-thirds of its vacuum speed, so a signal covers about 200 kilometres per millisecond. A 10,000 km path therefore imposes around 50 milliseconds each way as a floor, before any switching, routing or processing — and a round trip, from hand movement to visual confirmation, is double that. Real networks add considerably more.
For imaging, that delay is tolerable. An ultrasound operator moving a probe over an abdomen is working on a timescale of seconds; a tenth of a second of lag is an inconvenience, not a danger. The task is also forgiving — a mis-angled probe produces a poor image, which you correct.
For surgery, it is not. A surgeon cutting near a vessel depends on immediate visual confirmation to stop. Latency means the image shows where the instrument was, not where it is, and an error that would be arrested instantly at the bedside continues for the duration of the delay. This is why remote surgery has been demonstrated over moderate distances under controlled conditions and is not routine practice, and why the serious near-term applications of tele-robotics are diagnosis, imaging, guidance and proctoring rather than remote cutting.
Which makes the Minister's reframing the right one: "Instead of the patient being referred to the doctor, it will be the doctor being referred to the patient." For a country where specialist expertise concentrates in a handful of cities, moving the expertise rather than the patient is the substantive gain — and most of that gain is available without anybody operating remotely at all.
Precision medicine and the genome
The second half of the address concerned precision medicine: treatment tailored to the individual rather than to the diagnosis. Two patients with the same disease may require different drugs, at different doses, because of differences in genetic profile, environmental conditions, lifestyle and dietary patterns.
The enabling infrastructure is genomic. Dr Singh said the Genome India Programme has sequenced 10,000 individuals, and expressed the hope that India might move towards gene sequencing for every newborn — adding that doing so for a population of 1.4 billion would require the optimal use of AI and robotics.
That last observation is the practically important one, and it is a point about scale rather than ambition. Sequencing produces enormous volumes of data, and the bottleneck in genomic medicine has long since ceased to be the sequencing itself — it is interpretation. Determining which of the millions of variants in an individual genome is clinically actionable is a pattern-recognition problem at a scale no clinical workforce can address manually. Robotics addresses the sample-handling end — automated library preparation and high-throughput laboratory work — and AI the interpretation end. Neither alone is sufficient.
He also pointed to nanomedicine, citing work towards oral insulin — a long-standing problem, since insulin is a protein that the digestive system breaks down before absorption, which is why it is injected. Nano-scale delivery vehicles that protect the molecule through the stomach and release it for absorption would change the management of diabetes for a very large number of people. Indian work on nano-scale delivery, including gene-silencing nanomedicine for cancer, sits in the same technical territory.
The reason this matters for India specifically
The Minister grounded the case in India's epidemiological position: infectious diseases continuing to coexist with metabolic and lifestyle disorders, and conditions traditionally associated with later life appearing increasingly among younger people — the dual burden explored through the metabolic nexus.
A country with that profile cannot choose between infectious-disease public health and chronic-disease specialist care; it needs both simultaneously, across a population spread over enormous distances with specialists concentrated in cities. That is an argument for technologies that extend reach rather than merely deepen capability at the top — and it places robotics alongside the digital health infrastructure of ABDM and AI in the medical device sector rather than as a separate frontier.
The sober qualification: robotic surgical systems are expensive, both to buy and per procedure, and the evidence that they improve outcomes over conventional minimally invasive surgery is strong for some procedures and thin for others. A technology that extends a specialist's reach is valuable in a country short of specialists. A technology that makes an operation more expensive without making it better is not, and distinguishing the two case by case is the actual work.
🔑 Revision block
- 2 October 2026: Dr Jitendra Singh, MoS (I/C) Science and Technology and Earth Sciences, delivered the inaugural address at the International Conference of the Society of Robotic Surgery (SRS India 2026).
- Core claim: robotics is a tool that will extend across every medical specialty — "robotic medicine, robotic endocrinology, robotic cardiology" — not a surgery-specific technology.
- A surgical robot is a master-slave system. It is not autonomous and makes no decisions: the surgeon at a console drives robotic arms holding instruments.
- What it adds: tremor filtration (removing physiological hand tremor), motion scaling (large hand movement to small instrument movement), extra degrees of freedom through wristed instruments, and ergonomics.
- What it lacks: little or no haptic feedback — the surgeon substitutes vision for touch.
- Latency is the binding constraint on tele-robotics. Signals travel about 200 km per millisecond in optical fibre, so 10,000 km imposes roughly 50 ms each way as a floor, doubled for a round trip, before switching and processing.
- Imaging tolerates latency; surgery does not — a surgeon needs immediate visual confirmation to stop. Near-term tele-robotics is therefore diagnosis, imaging, guidance and proctoring.
- The Minister reported performing a robotic ultrasonography on a person 10,000 km away in Antarctica, and framed the shift as "the doctor being referred to the patient" rather than the reverse.
- Precision medicine: treatment tailored to the individual by genetic profile, environmental conditions, lifestyle and dietary patterns, rather than to the diagnosis alone.
- Genome India Programme: 10,000 individuals sequenced; aspiration towards sequencing every newborn, which for 1.4 billion people would require AI and robotics.
- The genomic bottleneck is interpretation, not sequencing — identifying which variants are clinically actionable. Robotics addresses sample handling; AI addresses interpretation.
- Nanomedicine and oral insulin: insulin is a protein digested before absorption, hence injection. Nano-scale delivery that protects it through the stomach would change diabetes management.
- India's dual disease burden: infectious diseases coexisting with metabolic and lifestyle disorders, with later-life conditions appearing in younger people.
- Caution: robotic systems are costly, and outcome evidence versus conventional minimally invasive surgery is strong for some procedures and thin for others.
🎯 Practice MCQs
Q1. A robotic surgical system is best described as: (a) An autonomous system that plans and executes the operation (b) A master-slave system in which the surgeon's movements drive the instruments (c) A pre-programmed device following a fixed surgical sequence (d) An imaging system with no instrument control
→ (b) It is a master-slave arrangement: every instrument movement originates with the surgeon at a console. The system refines the movement mechanically but exercises no judgement and operates nothing autonomously.
Q2. 'Motion scaling' in robotic surgery refers to: (a) Adjusting the magnification of the endoscopic image (b) Varying the speed of instrument exchange (c) Translating a large hand movement into a proportionally smaller instrument movement (d) Increasing the force applied by the instrument tip
→ (c) Motion scaling converts, say, a three-centimetre hand movement into a three-millimetre instrument movement, delivering precision beyond unaided human capability. Image magnification is a separate feature.
Q3. The principal sensory limitation of most current robotic surgical systems is the absence of: (a) Three-dimensional vision (b) Instrument articulation (c) Tremor filtration (d) Haptic feedback
→ (d) Most systems provide little or no haptic feedback, so the surgeon cannot feel tissue resistance and must infer it visually. Three-dimensional vision, articulation and tremor filtration are all features such systems do provide.
Q4. The decisive technical obstacle to routine long-distance tele-surgery is: (a) Signal latency between surgeon input and visual confirmation (b) Insufficient bandwidth for video transmission (c) The weight of the robotic arms (d) Lack of sterilisable instruments
→ (a) Latency is the binding constraint. The image shows where the instrument was, so an error that would be arrested instantly at the bedside continues for the duration of the delay.
Q5. Remote ultrasonography is more feasible than remote surgery over the same distance principally because imaging: (a) Requires no trained operator at either end (b) Transmits far less data (c) Operates on a timescale that tolerates delay, and errors are correctable rather than dangerous (d) Uses radio rather than optical transmission
→ (c) A probe operator works over seconds and a mis-angled probe merely yields a poor image, which can be corrected. Surgery depends on immediate confirmation to stop, which latency denies.
Q6. In optical fibre, a signal covers approximately how much distance per millisecond? (a) 20 km (b) 2,000 km (c) 300 km (d) 200 km
→ (d) Light in fibre travels at roughly two-thirds of its vacuum speed, giving about 200 km per millisecond. A 10,000 km path therefore implies around 50 ms each way as a theoretical floor.
Q7. 'Precision medicine' means treatment tailored to: (a) The individual patient's genetic profile, environment, lifestyle and diet (b) The average response observed in clinical trials (c) The cheapest therapeutic option available locally (d) The diagnosis alone, standardised across patients
→ (a) Precision medicine individualises treatment, recognising that two patients with the same diagnosis may need different drugs or doses. Option (d) describes conventional practice, which precision medicine seeks to move beyond.
Q8. The Genome India Programme was reported to have sequenced how many individuals? (a) 1,000 (b) 10,000 (c) 1,00,000 (d) 10 lakh
→ (b) 10,000 individuals, with the stated aspiration of eventually moving towards sequencing every newborn — a scale that would require AI and robotics to be feasible.
Q9. The principal bottleneck in applying genomics clinically at population scale is: (a) The cost of sequencing machines (b) A shortage of blood collection facilities (c) Interpreting which of an individual's genetic variants are clinically actionable (d) The unavailability of reference genomes
→ (c) Sequencing has become comparatively cheap and fast; interpretation has not. Identifying actionable variants among millions is a pattern-recognition problem at a scale manual clinical review cannot meet — hence the role of AI.
Q10. Insulin must currently be injected rather than taken orally because it is: (a) Unstable at room temperature (b) Too large to pass through the intestinal wall under any circumstances (c) Only effective when delivered directly to the pancreas (d) A protein that is broken down by the digestive system before absorption
→ (d) Insulin is a protein and is digested before it can be absorbed. Nano-scale delivery vehicles that protect it through the stomach and release it for absorption are the route to an oral formulation.
📋 How this gets asked (PYQ pattern)
Science and technology questions in the NDA paper reward understanding of mechanism, and this topic offers three clusters of it.
The first is how a stated technology actually functions. Master-slave control, tremor filtration, motion scaling, degrees of freedom, haptic feedback. A question describing a capability and asking which technology provides it is standard, and the absence of haptic feedback is the detail most often tested because it is counter-intuitive.
The second is physics applied to a real constraint. The speed of light in a medium, and therefore latency over distance, is a straightforward calculation that explains a real-world limitation. Questions of this kind — give a distance, ask about feasibility — reward a candidate who can reason rather than recall.
The third is India's biotechnology and health programmes: the Genome India Programme, BioE3 policy, the National Biopharma Mission, ABDM for digital health infrastructure, and ICMR's role in medical research. Each has a nodal agency, and the agency is the question.
A fourth pattern worth preparing is the distinction between precision, personalised, preventive and predictive medicine — the "four Ps" that appear together in policy documents and are routinely swapped in options. Precision means tailored to individual biology; preventive means acting before disease; predictive means forecasting risk; personalised is often used interchangeably with precision. Knowing which is which is cheap marks.
Preparing for NDA? For any new medical technology, ask what it adds and what it removes. Robotic surgery adds precision and removes touch; tele-robotics adds reach and adds latency. The trade-off is almost always where the question is set. Build the base with our NDA general ability notes, follow the daily NDA current affairs, and prepare with our faculty in the upcoming Cavalier courses in Delhi.
✍️ Written by Col Vijyanat Thakur — Defence studies faculty at The Cavalier. Reviewed by the Cavalier Faculty Desk.